Here’s What Analysts Are Saying About Teva Pharmaceutical (TEVA) Post Earnings

1 month ago 20

Noor Ul Ain Rehman

Tue, February 10, 2026 astatine 5:41 AM CST 2 min read

Teva Pharmaceutical Industries Limited (NYSE:TEVA) is 1 of the champion healthcare stocks nether $50 to put in. Barclays maintained an Overweight standing connected Teva Pharmaceutical Industries Limited (NYSE:TEVA) connected January 30, adjusting the terms people connected the banal to $38 from $35. It told investors that it updated the company’s exemplary aft the fiscal Q4 report, and expressed assurance successful the shares astatine these levels.

Among Small-Cap Healthcare Stocks Hedge Funds is Buying

In summation to Barclays, Scotiabank besides raised the terms people connected Teva Pharmaceutical Industries Limited (NYSE:TEVA) to $40 from $35 connected January 29 and maintained an Outperform standing connected the shares. The steadfast expressed optimism for the banal aft the fiscal Q4 results, and told investors successful a probe enactment that it upgraded the terms people due to the fact that of the company’s execution continually surpassing expectations.

The standing updates came aft Teva Pharmaceutical Industries Limited (NYSE:TEVA) announced connected January 28 that it delivered 3 consecutive years of growth, with 2025 revenues of $17.3 billion, reflecting a 4% year-over-year maturation successful U.S. dollars, oregon 3% successful section currency terms, compared to 2024. Revenues roseate 5% YoY successful section currency, excluding Japan BV. The company’s cardinal innovation brands continued to thrust growth, with 2025 revenues exceeding $3 billion, up 35% year-over-year successful section currency. Fiscal Q4 2025 marked the archetypal 4th successful which these brands collectively delivered ~$1 cardinal of revenues.

Teva Pharmaceutical Industries Limited (NYSE:TEVA) develops, produces, and sells medicines. Its operations are divided into the US, Europe, and International Markets geographical segments. Each concern conception covers the full merchandise portfolio successful that region, including specialty, generics, and over-the-counter (OTC) products.

While we admit the imaginable of TEVA arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you’re looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.

READ NEXT: 30 Stocks That Should Double successful 3 Years and 11 Hidden AI Stocks to Buy Right Now.

Disclosure: None. This nonfiction is primitively published at Insider Monkey.